# Safety and Bioavailability of IV and SC LBR-101

> **NCT01991509** · PHASE1 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 36 (actual)

## Conditions studied

- Bioavailability and Pharmacokinetics

## Interventions

- **BIOLOGICAL:** LBR-101 IV
- **BIOLOGICAL:** LBR-101 SC

## Key facts

- **NCT ID:** NCT01991509
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-12
- **Final completion:** 2015-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01991509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01991509, "Safety and Bioavailability of IV and SC LBR-101". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01991509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*